课题基金 / 基金详情

A study of Infection prevention from a new viewpoint responsible for untreated HIV patients and their cognition

A study of Infection prevention from a new viewpoint responsible for untreated HIV patients and their cognition
从新的角度进行感染预防研究,负责未治疗的艾滋病毒患者及其认知
批准号:
19590618
负责人:
MAKIE Toshio
金额:
$1.58万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2007
资助国家:
日本
项目状态:
已结题
起止时间:
2007 至 2009

项目摘要

项目成果

MAKIE Toshio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We examined three assignments responsible for HIV patients before medication introduction ; 1) seasonal variation in CD4+ cell counts, 2) estimating CD4+ cell counts of an individual using population historical data, and 3) a feature in Japanese patients before medication introduction. The results indicated as follows ; 1) HIV patient's CD4+ cell counts decreases in early summer and increases in autumn in Japan, 2) our new method has potential that the relative coefficient between the predicted and actual CD4-counts keeps above 0.8 even in 12 month intervals, and 3) Japanese HIV patients have a feature of either the slow first hospital visit or the fast progression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predicting Tenofovir Concentration Based on Renal Factors Determined by Routine Tests Am
根据常规测试确定的肾脏因素预测替诺福韦浓度
DOI: --
发表时间: 2007
期刊: J Therapeu 14(6)
影响因子: --
作者: [Makie T, Nagai S, Sasakawa A, Kawamura K, Kuwahara T]
通讯作者: Kuwahara T
治療法がなかった時代における患者へのアプローチと考察
无治疗时代患者的应对方法和注意事项
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Ahmed, S., Tsukahara, S., Win-Shwe, T.T., Yamamoto, S., Kunugita, N., Arashidani, K., Fujimaki, H., 牧江俊雄]
通讯作者: 牧江俊雄
DOI: 10.2152/jmi.55.156
发表时间: 2008-02-01
期刊: JOURNAL OF MEDICAL INVESTIGATION
影响因子: 0.7
作者: [Kuwahara, Takeshi, Nakakura, Takahiro, Yamamoto, Yoshihiko]
通讯作者: Yamamoto, Yoshihiko
Monthly variation in CD4+ cell counts in HIV patients
HIV 患者 CD4 细胞计数的每月变化
DOI: --
发表时间:
期刊: AIDS research and treatment
影响因子: 1.7
作者: [Makie T, Ishida N, Sato S, Ono A, Yamamoto Y, Nakamura T]
通讯作者: Nakamura T
12
    A study of evaluating issue of the drug development scientifically and predicting the adaptive development quantitatively.
    海外基金